2024-06-15 11:19:01 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: The Road To Approval Of Donanemab Is Open
- Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference
- Novo Nordisk CEO to testify before Senate on Ozempic pricing
- Employee benefits survey finds marked increase in GLP-1 coverage
Read the full article on Seeking Alpha
For further details see:
U.S. drug shortages worsen to reach a decade high: report